Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02505425 · ClinicalTrials.gov registry record · NA

ENABLE CHF-PC (Comprehensive Heartcare For Patients and Caregivers)

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
573
Enrollment target

NCT02505425 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 573 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02505425, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
573 participants
Enrollment target

Study Summary

Advanced heart failure affects nearly 6 million Americans, and less is known about how this illness affects the 80% of heart failure patients who are 65 years and older because research tends to focus on younger patients. Older patients with heart failure and their family caregivers, rarely have access to palliative supportive care services because the disease is unpredictable and palliative treatment may not be provided until after other medical treatments have been tried. Investigators are studying whether palliative care provided when advanced heart failure patients are still well will result in better quality of life, mood and less symptom distress compared to usual or standard heart failure care. Specific Aims and Hypotheses: Specific Aim 1: Determine whether ENABLE CHF-PC leads to higher advanced heart failure patient-reported quality of life (QOL) and mood (depression/anxiety); and lower symptom burden and resource use (e.g. hospital admissions and days, emergency visits) through 16 weeks post baseline. • Hypothesis 1: Intervention participants will experience higher QOL and mood, and lower symptom burden and resource use through 16 weeks post baseline compared with those receiving usual HF care. Specific Aim 2: Determine whether ENABLE CHF-PC leads to higher caregiver-reported QOL, mood (anxiety/depression), and self-reported health and lower caregiver burden through 16 weeks post baseline. • Hypothesis 2: Intervention caregivers will report higher QOL, mood, and self-reported health, and lower caregiver burden through 16 weeks post baseline.

Interventions

  • BEHAVIORAL Behavioral Support
  • BEHAVIORAL Usual HF Care

Trial Details

FieldValue
Enrollment Target 573 participants
Start Date 2015-11-30
Est. Completion 2019-05-10
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT02505425

The ClinicalTrials.gov registry entry for NCT02505425 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 573 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Behavioral Support is the first listed.

NCT02505425 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02505425 about?

NCT02505425 is a clinical study titled "ENABLE CHF-PC (Comprehensive Heartcare For Patients and Caregivers)". Advanced heart failure affects nearly 6 million Americans, and less is known about how this illness affects the 80% of heart failure patients who are 65 years and older because research tends to focus on younger patients. Older patients with heart failure and their family caregivers, rarely have acc...

What is the current status of trial NCT02505425?

This trial is currently completed. It is a NA study. The enrollment target is 573 participants. The study started on 2015-11-30. Estimated completion is 2019-05-10.

What interventions are being tested in trial NCT02505425?

The interventions under investigation include: Behavioral Support (BEHAVIORAL), Usual HF Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT02505425?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.